[C:1]([OH:13])(=[O:12])[CH2:2][C:3]([CH2:8][C:9]([OH:11])=[O:10])([C:5]([OH:7])=[O:6])[OH:4].[C:14]([O-:26])(=[O:25])[CH2:15][C:16]([CH2:21][C:22]([O-:24])=[O:23])([C:18]([O-:20])=[O:19])[OH:17].[Na+:27].[Na+].[Na+]>O>[C:1]([OH:13])(=[O:12])[CH2:2][C:3]([CH2:8][C:9]([OH:11])=[O:10])([C:5]([OH:7])=[O:6])[OH:4].[C:14]([O-:26])(=[O:25])[CH2:15][C:16]([CH2:21][C:22]([O-:24])=[O:23])([C:18]([O-:20])=[O:19])[OH:17].[Na+:27].[Na+:27].[Na+:27]A citric acid/sodium citrate buffer was prepared by dissolving 2.7 g citric acid and 11.3 g sodium citrate in 100 ml of distilled/deionised water and dissolving 400 mg of SPMP into this solution. A 500 μl sample of this solution was dispensed into the bottom of individual SafeTube® reaction chambers. This 500 μl sample contains 56.6 mg sodium citrate, 13.5 mg citric acid and 2 mg SPMP.